Skip to content
Screener

Total Liabilities at other companies

Abbott logo
AbbottABT
$4.61B
Boston Scientific logo
Boston ScientificBSX
$1.58B
Medtronic logo
MedtronicMDT
$42.96B-1.1%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$21M+8.5%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$38.04M+7.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.09B+5.1%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by Kestra Medical Technologies in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397
Line itemApril 30, 2026April 30, 2025
Warrant liabilities1,3698,097
Other long-term liabilities306140
Long-term debt, net42,64941,098
Total liabilities98,80790,338
Commitments and contingencies (Note 14)
Shareholders’ equity
Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 202558,38451,349
Additional paid-in capital853,353674,306

Item 16. Form 10-K Summary.

FAQ

What is Kestra Medical Technologies's total liabilities?
Kestra Medical Technologies (KMTS) reported total liabilities of $98.81M in Q1 2026.
How has Kestra Medical Technologies's total liabilities changed year-over-year?
Kestra Medical Technologies's total liabilities increased by 9.4% year-over-year, from $90.34M to $98.81M.
What is the long-term trend for Kestra Medical Technologies's total liabilities?
Over 2 years (2024 to 2026), Kestra Medical Technologies's total liabilities has grown at a 12.4% compound annual growth rate (CAGR), from $78.22M to $98.81M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Kestra Medical Technologies's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude